By quantifying both PI9 inhibition and killing at single-cell resolution, we are able to demonstrate that while tumor cell PI9 overexpression does inhibits GZMB activity as expected, this inhibition surprisingly does not result in reduced cytotoxicity of CAR T cells. This evidence concerns the gene GZMB and neoplasm.